Medisurge Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 26-06-2024
- Paid Up Capital ₹ 1.26 M
as on 26-06-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 73.00 M
as on 26-06-2024
- Revenue 0.39%
(FY 2022)
- Profit -63.21%
(FY 2022)
- Ebitda -52.87%
(FY 2022)
- Net Worth 22.78%
(FY 2022)
- Total Assets 4.72%
(FY 2022)
About Medisurge Technologies
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.26 M.
The company has closed loans amounting to ₹7.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tapas Chaterjea and Anand Chatterjee serve as directors at the Company.
- CIN/LLPIN
U74900DL2009PTC189975
- Company No.
189975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2009
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medisurge Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Chatterjee  | Director | 04-Mar-2011 | Current |
| Tapas Chaterjea | Director | 06-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Medisurge Technologies.
Medisurge Technologies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.39% increase. The company also saw a substantial fall in profitability, with a 63.21% decrease in profit. The company's net worth Soared by an impressive increase of 22.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisurge Technologies?
In 2019, Medisurge Technologies had a promoter holding of 77.31% and a public holding of 22.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Aug 2016 | ₹2.50 Cr | Satisfied |
Sidbi Creation Date: 04 Sep 2014 | ₹3.80 Cr | Satisfied |
Indian Overseas Bank Creation Date: 26 Feb 2013 | ₹5.00 M | Satisfied |
How Many Employees Work at Medisurge Technologies?
Medisurge Technologies has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisurge Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisurge Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
